It has been reported that gene therapy targeting HER-2 promotes tumor cell apoptosis and restrains tumor cell invasion as well as tumor angiogenesis via blocking the PI3K/AKT/mTOR pathway [45]. Here, ERBB2 is linked to neoplasm.